The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
Open accessAbstract
Mutation-dependent overproduction of intrinsic β-lactamase AmpC is considered the main cause of resistance of clinical strains of Pseudomonas aeruginosa to antipseudomonal penicillins and cephalosporins. Analysis of 31 AmpC-overproducing clinical isolates exhibiting a greater resistance to ceftazidime than to piperacillin-tazobactam revealed the presence of 17 mutations in the β-lactamase, combined with various polymorphic amino acid substitutions. When overexpressed in AmpC-deficient P. aeruginosa 4098, the genes coding for 20/23 of these AmpC variants were found to confer a higher (2-fold to >64-fold) resistance to ceftazidime and ceftolozane-tazobactam than did the gene from reference strain PAO1. The mutations had variable effects on the MICs of ticarcillin, piperacillin-tazobactam, aztreonam, and cefepime. Depending on their location in the AmpC structure and their impact on β-lactam MICs, they could be assigned to 4 distinct groups. Most of the mutations affecting the omega loop, the R2 domain, and the C-terminal end of the protein were shared with extended-spectrum AmpCs (ESACs) from other Gram-negative species. Interestingly, two new mutations (F121L and P154L) were predicted to enlarge the substrate binding pocket by disrupting the stacking between residues F121 and P154. We also found that the reported ESACs emerged locally in a variety of clones, some of which are epidemic and did not require hypermutability. Taken together, our results show that P. aeruginosa is able to adapt to efficacious β-lactams, including the newer cephalosporin ceftolozane, through a variety of mutations affecting its intrinsic β-lactamase, AmpC. Data suggest that the rates of ESAC-producing mutants are ≥1.5% in the clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mutations in the β-lactamase gene ampC causes a significant increase in resistance to cephalosporins.258”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [258]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals
Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G., & Ausubel, F. M. (1995) · Science · doi:10.1126/science.7604262 · Cited by 1,339
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Genetic Recombination in Pseudomonas aeruginosa
HOLLOWAY, B. W. (1955) · Microbiology · doi:10.1099/00221287-13-3-572 · Cited by 650
West, S. E. H., Schweizer, H. P., Dall, C., Sample, A. K., & Runyen-Janecky, L. J. (1994) · Gene · doi:10.1016/0378-1119(94)90237-2 · Cited by 567
Curran, B., Jonas, D., Grundmann, H., Pitt, T., & Dowson, C. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5644-5649.2004 · Cited by 509
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Cabot, G., Ocampo-Sosa, A. A., Domínguez, M. A., Gago, J. F., Juan, C., Tubau, F., Rodríguez, C., Moyà, B., Peña, C., Martínez-Martínez, L., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-12 · Cited by 227
Dumas, J.-L., Delden, C., Perron, K., & Köhler, T. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2005.00008.x · Cited by 224
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-08 · Cited by 211
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Cephalosporinase and penicillinase activities of a β-lactamase from Pseudomonas pyocyanea
Sabath, L., Jago, M., & Abraham, E. (1965) · Biochemical Journal · doi:10.1042/bj0960739 · Cited by 190
Henrichfreise, B., Wiegand, I., Pfister, W., & Wiedemann, B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00148-07 · Cited by 179
Castanheira, M., Mills, J. C., Farrell, D. J., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03681-14 · Cited by 141
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Aminoglycoside Efflux in Pseudomonas aeruginosa : Involvement of Novel Outer Membrane Proteins
Jo, J. T. H., Brinkman, F. S. L., & Hancock, R. E. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1101-1111.2003 · Cited by 125
Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., & Nishino, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.400 · Cited by 114
Hocquet, D., Berthelot, P., Roussel‐Delvallez, M., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00503-07 · Cited by 102
Fung-Tomc, J. C., Dougherty, T. J., DeOrio, F. J., et al. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.498 · Cited by 73
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa
Tam, V. H., Schilling, A. N., LaRocco, M., Gentry, L. O., Lolans, K., Quinn, J. P., & Garey, K. W. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01674.x · Cited by 71
Drawz, S. M., Taracila, M. A., Caselli, E., Prati, F., & Bonomo, R. A. (2011) · Protein Science · doi:10.1002/pro.612 · Cited by 51
Warren, A., Boulianne-Larsen, C. M., Chandler, C. B., Chiotti, K., Kroll, E., Miller, S. R., Taddéi, F., Sermet‐Gaudelus, I., Ferroni, A., McInnerney, K., et al. (2011) · Infection and Immunity · doi:10.1128/iai.05282-11 · Cited by 47
Fernández-Olmos, A., García-Castillo, M., Alba, J. M., Morosini, M. I., Lamas, A., Romero, B., Galán, J. C., del Campo, R., & Cantón, R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00802-13 · Cited by 38
Crémet, L., Caroff, N., Giraudeau, C., Reynaud, A., Caillon, J., & Corvec, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks520 · Cited by 29
García-Castillo, M., Máiz, L., Morosini, M.-I., Rodríguez-Baños, M., Suárez, L., Fernández-Olmos, A., Baquero, F., Cantón, R., & del Campo, R. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05478-11 · Cited by 27
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Metadata
- Authors
- Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-10
- Volume
- 59
- Issue
- 10
- Pages
- 6248-6255
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1959513603
- Cited by
- 268
- References
- 31
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.